Subscribe To
Pfizer slashes full-year earnings and revenue guidance as covid treatment, vaccine sales slump
Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion les...
October 13, 2023, 5:47 pm
Novavax (nvax) stock slides despite vaccine availability
Despite seemingly good news, shares of biotechnology firm Novavax (NASDAQ: NVAX ) suffered a significant decline. Earlier Friday morning, management a...
October 13, 2023, 1:38 pm
New rsv protections for infants hit cost, insurance hurdles in u.s. rollout
Pfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expe...
October 13, 2023, 12:22 pm
Novavax's updated covid-19 vaccines available in us pharmacies
Novavax said on Friday its updated COVID-19 vaccine was available across pharmacies in the United State...
October 13, 2023, 9:33 am
Walgreens' ceo faces multiple challenges ahead: analyst
Walgreens new CEO, Tim Wentworth, has multiple challenges ahead to generate profitability as the company transitions into providing healthcare beyond ...
October 12, 2023, 11:35 am
Walgreens profit outlook comes up short as demand declines for covid vaccines and tests
CNBC's Bertha Coombs reports on the retail pharmacy giant's quarterly earnings results....
October 12, 2023, 8:27 am
Walgreens profit outlook comes up short as demand declines for covid vaccines and tests
Walgreens has now underperformed Wall Street's adjusted earnings expectations for two straight quarters....
October 12, 2023, 7:01 am
Walgreens reports $180 million loss ahead of new ceo taking over
Walgreens Boots Alliance reported a $180 million loss in the company's fiscal fourth quarter thanks in part to “significantly lower COVID-19 v...
October 12, 2023, 7:00 am
Fda finds no misconduct at trial sites for pfizer's lyme disease shot- care access
The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer and French partner Valneva's trial of a Lyme...
October 11, 2023, 1:21 pm
Valneva to present on chikungunya at several leading scientific conferences
Saint-Herblain (France), October 11, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vacc...
October 11, 2023, 11:45 am
Presentations at idweek 2023 highlight potentially differentiated immunogenicity of gritstone bio’s next generation covid-19 vaccine
— High neutralizing antibody (nAb) responses sustained through at least 12 months, highlighting potential for durable clinical protection — — T ...
October 11, 2023, 11:10 am
Vaxart to present at world vaccine congress europe 2023 on october 18-19
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Sci...
October 11, 2023, 8:00 am
Novavax (nvax) focuses on diversifying vaccines portfolio
Owing to the slow uptake of Novavax's (NVAX) COVID-19 vaccine, the company is trying to develop other v...
October 10, 2023, 1:33 pm
Ocugen mucosal vaccine candidate ocu500 selected by nih/niaid project nextgen for inclusion in clinical trials
NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the i...
October 10, 2023, 10:30 am
Why is ocugen (ocgn) stock up 5% today?
Ocugen (NASDAQ: OCGN ) stock is on the rise Tuesday after the clinical-stage biopharmaceutical company announced a new v...
October 10, 2023, 9:58 am
Novavax's covid-19 investment thesis is old news
NVAX's H2'23 estimates appear to be overly bullish, based on PFE's pessimistic commentary with only 24% of the US population likely to be v...
October 9, 2023, 4:00 pm
Updated novavax covid-19 vaccine shipped to distributors, to be available this week
Vaccine maker Novavax Inc on Monday said it has shipped its updated COVID-19 shots to distributors afte...
October 9, 2023, 12:22 pm
Walgreens boots alliance faces disappointment: prepare for more struggles in sight
Walgreens Boots Alliance is one of the key players in the healthcare industry and one of the world's largest retail pharmacies, headquartered in Deerf...
October 9, 2023, 6:22 am
Gsk inks £2.5bn shingles vaccine deal with china's zhifei
GSK PLC (LSE:GSK, NYSE:GSK) has inked an exclusive three-year agreement, £2.5 billion with China's Zhifei to co-promote its shingles v...
October 9, 2023, 3:12 am
Gsk signs shingles vaccine deal with china's zhifei for about $3 bln
GSK , on Monday, announced an exclusive partnership with China's Chongqing Zhifei Biological Products (Zhifei) for its shingles v...
October 9, 2023, 2:18 am